Biotech

Latest Articles

Cassava pays $40M over allegedly deceiving Alzheimer's update

.Cassava Sciences has accepted spend $40 thousand to deal with an investigation in to cases it made ...

Merck bags possibilities on Evaxion's AI-designed vaccination candidates

.Merck &amp Co. has picked up possibilities on pair of Evaxion Biotech injection prospects, spending...

Enanta's RSV antiviral crushes viral lots in obstacle research

.Enanta Pharmaceuticals has actually linked its own breathing syncytial infection (RSV) antiviral to...

Biogen cans SAGE-324 cooperation after crucial shake stop working

.Biogen has provided the last ceremonies to its cooperation with Sage Therapies on SAGE-324, junking...

AbbVie Parkinson's medication from $8.7 B Cerevel buyout scores

.On the very same day that some Parkinson's ailment medicines are being cast doubt on, AbbVie has ac...

Arch shuts $3B-plus fund to nurture biopharma upstarts

.On the heels of a $3 billion fund coming from Bain Resources Lifestyle Sciences, Arc Venture Allies...

Orion to use Aitia's 'digital identical twins' to find brand-new cancer medicines

.Finnish biotech Orion has snooped prospective in Aitia's "digital twin" technology to establish new...

Windtree's surprise med rears high blood pressure in most up-to-date phase 2 succeed

.While Windtree Rehabs has struggled to develop the monetary origins required to endure, a stage 2 s...

2 cancer biotechs combine, producing international impact

.OncoC4 is taking AcroImmune-- and its own internal scientific manufacturing capabilities-- under it...

Amgen reports initial period 3 gain for $400M chronic eczema medication

.Amgen has discussed (PDF) the first phase 3 records on its $400 million eczema drug, connecting the...

Biogen, UCB report phase 3 lupus win after stopping working earlier trial

.Biogen and UCB's depend developing right into phase 3 on the back of a failed research study looks ...

Aptadir hopes brand-new RNA preventions may reverse difficult cancers cells

.Italian biotech Aptadir Rehabs has released with the pledge that its own pipe of preclinical RNA pr...

Wave surfs DMD success to regulators' doors, delivering stockpile

.Surge Lifestyle Sciences has met its own objective in a Duchenne muscular dystrophy (DMD) study, pl...

Sanofi tweezes brand new CSO coming from in-stealth biotech

.After a handful of years in biotech, Mike Quigley, Ph.D., is coming back to the pharma fold, using ...

Achilles trickles tissue treatment system, prepares for unemployments after missing 'commercial viability' targets

.Achilles Therapies has wrecked its strategy. The English biotech is actually stopping work on its c...

Aligos proclaims period 2 MASH win, reducing liver excess fat as much as 46%

.Aligos Therapies is actually advertising a midstage succeed in metabolic-dysfunction associated ste...

Basilea scores $268M BARDA backing for antifungals, anti-biotics

.Basilea Pharmaceutica's job developing new antifungals has acquired a considerable increase from th...

Capricor markets Europe rights to late-stage DMD treatment for $35M

.Possessing currently gathered up the USA rights to Capricor Therapies' late-stage Duchenne muscle d...

FDA fragments adcomm for Applied's unusual health condition drug

.After dismissing the decision date for Applied Therapeutics' metabolic condition medicine govoresta...

Novo inks $600M NanoVation package to examine hereditary medications ex-liver

.Novo Nordisk is actually proceeding its own push in to genetic medications, accepting pay NanoVatio...